• Non ci sono risultati.

Cadmium exposure and risk of breast cancer: a meta-analysis.

N/A
N/A
Protected

Academic year: 2021

Condividi "Cadmium exposure and risk of breast cancer: a meta-analysis."

Copied!
2
0
0

Testo completo

(1)

1

PROGRAM

ISEE-Europe’s

2

nd

Early

Career Researchers

Conference

on

Environmental Epidemiology

2-3 November 2015

Utrecht, The Netherlands

(2)

ISEE Europe Young 2015 - 2nd Early Career Researchers Conference on Environmental Epidemiology

IRAS, Utrecht, the Netherlands, 2nd -3rd November 2015

Connect to shape the future

105

Abstract ID: 74

Title: Cadmium exposure and risk of breast cancer: a meta-analysis Presenting Author: Filippini, T

Authors: Filippini, Tommaso (1); Vinceti, Marco (1)

Affiliations: (1) CREAGEN – Center of Environmental, Genetic and Nutritional Epidemiology,

University of Modena and Reggio Emilia, Modena, Italy

Text:

Background and aims: Cadmium (Cd) is a toxic metal with estrogenic activity and established

human carcinogenicity, but several uncertainties still exist about the amounts of relevant exposure and particularly the cancer types involved.

Methods: We carried out a systematic search in the PubMed-Medline database in April 2015,

using as MeSH terms ‘cadmium’, ‘breast cancer’, or ‘breast tumor’. We identified 24 eligible studies, 16 case-control and 8 cohort ones. We performed a meta-analysis according to study design and type of Cd exposure assessment, using random-effects model considering the moderate heterogeneity between these investigations.

Results: The exposure assessment methodology influenced the metaǦanalysis results, which

however generally indicated an increased risk of breast cancer. For studies using urine Cd

concentrations for exposure assessment, we found a summary relative risk (RR) of 2.14 (95% CI 1.37-3.34) and 1.39 (0.67-2.92) for case-control and cohort studies, respectively. For cohort studies using dietary Cd intake for exposure assessment, summary RR was 1.00 (0.87-1.15). Stratified analysis according to Estrogen Receptor (ER) status showed a summary RRs of 1.05 (0.94-1.16) and 1.00 (0.82-1.21) for positive and negative cancer types, respectively. For Progesterone Receptor (PR), RRs were 0.87 (0.69-1.10) and 1.10 (0.83-1.45) for positive and negative status, respectively. Considering body mass index (BMI) as effect modifier, RR was 1.08 (0.96-1.23) and 0.99 (0.93-1.05) for BMI<25 and BMI≥25, respectively.

Conclusions: Despite the limitations of this metaǦanalysis, such as the differences in exposure

assessment methods and the statistical imprecision of the point estimates, overall results appear to suggest a direct association between cadmium exposure and breast cancer, with higher RR in subgroups such as ER-positive, PR-negative and normal weight women.

Riferimenti

Documenti correlati

Also at University of Belgrade, Faculty of Physics and Vinca Institute of Nuclear Sciences, Belgrade, Serbia. rr Also at Scuola Normale e Sezione dell ’INFN,

Interestingly, using the citrulline-specific probe, we determined the overall pattern of citrullination during infection that changes consistently at different time points

When PM1-IIIB cells were stimulated with TNF-α , an increase of HLA-C free chains at the cell surface (L31 antibody) was observed (as in ACH-2 cells), which was barely detected

Lo mostrano nuovamente i dati numerici (messi opportunamente in rilievo da Quondam): se infatti nella Storia della letteratura italiana il nome di Dante ricorre 474 volte

di conversioneall 'Islam 4. La diffusione in epoca molto antica della religione ,e della cultura islamicbe nelle vaste profondità dell'altopiano interno offre una

With respect to Veneto region, based on the outcome of blood meal analysis and field census of this study (see Results section, chapter 4.3), four wild bird species were

The sample of bright XRBs in Table 1 have been observed and extensively studied with several X-ray observatories and represent the major “classes” of XRBs: BH systems with high and

Finally, we acknowledge the enduring support for the construction and operation of the LHC and the CMS detector provided by the following funding agencies: the Austrian Federal